Tetrahydro-11-deoxy cortisol
CAS: 68-60-0
Rif. 3D-FT28089
2mg | 136,00 € | ||
5mg | 206,00 € | ||
10mg | 330,00 € | ||
25mg | 560,00 € | ||
50mg | 902,00 € |
Informazioni sul prodotto
- (3α,5β)-3,17,21-Trihydroxypregnan-20-one5β-Pregnane-3α,17α,21-triol-20-one
- (3Alpha,5Beta)-3,17,21-Trihydroxypregnan-20-One
- (3α,5β)-3,17,21-Trihydroxypregnan-20-one
- 11-Deoxytetrahydrocortisol
- 3,17,21-Trihydroxypregnan-20-One
- 3alpha,17,21-Trihydroxy-5beta-pregnan-20-one
- 3α,17,21-Trihydroxy-5β-pregnan-20-one
- 3α,17α,21-Trihydroxy-5β-pregnan-20-one
- 3α,17α,21-Trihydroxy-5β-pregnane-20-one
- 5β-Pregnan-20-one, 3α,17,21-trihydroxy-
- Vedi altri sinonimi
- Cortexolone, tetrahydro-
- Cortisol, 11-deoxytetrahydro-
- Nsc 53901
- Pregnan-20-one, 3,17,21-trihydroxy-, (3alpha,5beta)-
- Pregnan-20-one, 3,17,21-trihydroxy-, (3α,5β)-
- Reichstein's substance S, tetrahydro-
- Tetrahydro S
- Tetrahydro-11-deoxy-17α-hydroxycorticosterone
- Tetrahydro-11-deoxycortisol
- Tetrahydro-11-desoxycortisol
- Tetrahydro-17-hydroxy-11-deoxycorticosterone
- Tetrahydrocortexolone
- Tetrahydrodeoxycortisol
Tetrahydro-11-deoxy cortisol (THDOC) is a synthetic corticosteroid that is used in the treatment of proliferative diabetic retinopathy. It has been shown to reduce the severity of retinal neovascularization in experimental models. THDOC has a hydroxyl group at position 11 and a double bond between C-11 and C-12, which are not present in natural cortisol. The body mass index (BMI) of women with high values for THDOC is correlated with the prevalence of adrenocortical carcinoma. This correlation suggests that THDOC may be useful as a diagnostic marker for this type of cancer.
Proprietà chimiche
Richiesta tecnica su: 3D-FT28089 Tetrahydro-11-deoxy cortisol
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.